Cambridge Biomedical Inc announces appointment of Anthony Davis as Director of Quality Assurance

Boston, MA (PRWEB) October 16, 2014

Cambridge Biomedical Inc announces the appointment of Anthony Davis as Director of Quality Assurance.

Anthony brings extensive experience with Quality Assurance and Compliance Systems from working with market leaders in the Life Sciences sector, including global responsibility for Quality Systems for a major biotech company based in Massachusetts.

Dr. John Reddington, Chief Operating Officer for Cambridge Biomedical commented that “ Our appointment of Anthony to this position within Cambridge Biomedical demonstrates our continuing commitment to quality in meeting the critical bioanalytical needs of our partners”.

Cambridge Biomedical 
Since 1997, Cambridge Biomedical has partnered with our clients by providing a diverse range of services from pre-clinical to post market. Including; assay development, optimization, validation and diagnostic testing. Conveniently located to support the North East pharmaceutical development market, yet with a national and global reach. Our personalized project management, approach along with a focus on delivering quality results and regulatory submission ready documentation and rapid turnaround times, ensure we meet our client’s product development timelines



Latest News   

 Subscribe to our blog


Cambridge Biomedical's Biannual Scientific Meeting - Microbiome Luncheon

Tuesday, December 12, 2017  11:30AM to 1:00PM

Catalyst Restaurant                  300 Technology Square,   Cambridge MA 02139

For existing clients & test results please contact 
Customer Service:617.456.0800
All rights reserved. Cambridge Biomedical, the Cambridge Biomedical logo, Science and Service, and Custom
Solutions for Life Sciences Companies are registered or unregistered trademarks of Cambridge Biomedical Inc.
|     Privacy Statement     | Terms of Use